Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Showing 20 of 0 results

Not applicableStudy completedNCT02910258
What this trial is testing

Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis

Who this might be right for
Myelofibrosis
University Hospital, Brest 62
Not applicableStudy completedNCT00216775
What this trial is testing

Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Kyoto University 50
Post-approval studies (Phase 4)Ended earlyNCT01592006
What this trial is testing

Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients

Who this might be right for
Hepatitis C
University of Chicago 3
Testing effectiveness (Phase 2)Ended earlyNCT00573378
What this trial is testing

Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
University of Michigan Rogel Cancer Center 12
Not applicableStudy completedNCT01142518
What this trial is testing

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 86
Testing effectiveness (Phase 2)UnknownNCT04246359
What this trial is testing

Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Huiqiang Huang 52
Testing effectiveness (Phase 2)Study completedNCT00436826
What this trial is testing

Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)

Who this might be right for
Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 172
Large-scale testing (Phase 3)Study completedNCT01716585
What this trial is testing

Evaluate Chronic Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 636
Not applicableWithdrawnNCT00838968
What this trial is testing

The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University
Not applicableStudy completedNCT01007058
What this trial is testing

Markers of Response to Intravesical Bladder Cancer Therapy

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 150
Large-scale testing (Phase 3)Study completedNCT01715415
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 395
Large-scale testing (Phase 3)Study completedNCT03719313
What this trial is testing

Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a

Who this might be right for
Hepatitis Delta Virus
Eiger BioPharmaceuticals 407
Early research (Phase 1)Study completedNCT00796770
What this trial is testing

Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

Who this might be right for
HIV
Baylor Research Institute 19
Large-scale testing (Phase 3)Study completedNCT00030966
What this trial is testing

Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 1,200
Testing effectiveness (Phase 2)Study completedNCT00623402
What this trial is testing

Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma

Who this might be right for
Melanoma
University Hospital Schleswig-Holstein 55
Not applicableStudy completedNCT04361786
What this trial is testing

Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection

Who this might be right for
COVID 19
University Hospital, Montpellier 10
Large-scale testing (Phase 3)Study completedNCT00420888
What this trial is testing

ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Active Biotech AB 526
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Not applicableStudy completedNCT00539773
What this trial is testing

Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

Who this might be right for
Transitional Carcinoma of Urinary Bladder
King Faisal Specialist Hospital & Research Center 10
Testing effectiveness (Phase 2)WithdrawnNCT00003405
What this trial is testing

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Rush University Medical Center
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation